Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Pursuing Low-Cost DTC Strategy For MIS 2 Incision Hip Surgery

This article was originally published in The Gray Sheet

Executive Summary

Obtaining local media coverage for Zimmer's MIS 2 incision hip replacement procedure is proving to be a cost-effective DTC strategy, according to CEO Ray Elliott

You may also be interested in...



Clash Of The Titans: Ortho Surgeons, Manufacturers Square Off On DTC Ads

Orthopedic firms should work with surgeons to craft carefully worded direct-to-consumer ads to prevent patients from requesting inappropriate procedures, participants agreed at the Cleveland Clinic's Medical Innovation Summit Oct. 25

Clash Of The Titans: Ortho Surgeons, Manufacturers Square Off On DTC Ads

Orthopedic firms should work with surgeons to craft carefully worded direct-to-consumer ads to prevent patients from requesting inappropriate procedures, participants agreed at the Cleveland Clinic's Medical Innovation Summit Oct. 25

Device Firms Miss “Backyard” Opportunities By Focusing On “Street”

Local media outlets may be more effective vehicles to educate consumers on medical device innovations than national news sources, Johnson & Johnson Medical Affairs VP Nancy Snyderman, MD, maintained at AdvaMed's annual meeting March 4

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020298

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel